Crystal structure of methyl (2Z)-2-[(2Z)-2-(2-cyclopentylidenehydrazin-1-yl-idene)-4-oxo-3-phenyl-1,3-thiazolidin-5-ylidene]ethanoate

被引:3
作者
Akkurt, Mehmet [1 ]
Smolenski, Victoria A. [2 ]
Mohamed, Shaaban K. [3 ,4 ]
Jasinski, Jerry P. [2 ]
Hassan, Alaa A. [4 ]
Albayati, Mustafa R. [5 ]
机构
[1] Erciyes Univ, Dept Phys, Fac Sci, TR-38039 Kayseri, Turkey
[2] Keene State Coll, Dept Chem, Keene, NH 03435 USA
[3] Manchester Metropolitan Univ, Chem & Environm Div, Manchester M1 5GD, Lancs, England
[4] Menia Univ, Fac Sci, Dept Chem, El Minia 61519, Egypt
[5] Kirkuk Univ, Dept Chem, Coll Sci, Kirkuk, Iraq
关键词
crystal structure; thiazolidinyl ring; disorder; hydrogen bonding; C-H center dot center dot center dot pi interactions;
D O I
10.1107/S2056989015017454
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
In the title compound, C17H17N3O3S, the cyclopentane ring is disordered over two sets of sites with an occupancy ratio of 0.775 (8): 0.225 (8) for the affected atoms. The thiazolidinyl ring is planar (r. m. s. deviation = 0.024 angstrom) and forms a dihedral angle of 65.13 (8)degrees with the attached phenyl ring. The molecular packing is stabilized by C-H center dot center dot center dot O and C-H center dot center dot center dot pi interactions, forming a three-dimensional structure.
引用
收藏
页码:O776 / U515
页数:10
相关论文
共 18 条
[1]  
Agilent, 2014, CRYSALIS PRO
[2]   New orally active non-peptide fibrinogen receptor (GpIIb-IIIa) antagonists: Identification of ethyl 3-[N-[4-[4-[amino[(ethoxycarbonyl)imino]methyl]phenyl]-1,3-thiazol-2-yl]-N-[1-[(ethoxycarbonyl)methyl]piperid-4-yl]amino]propionate (SR 121787) as a potent and long-acting antithrombotic agent [J].
Badorc, A ;
Bordes, MF ;
deCointet, P ;
Savi, P ;
Bernat, A ;
Lale, A ;
Petitou, M ;
Maffrand, JP ;
Herbert, JM .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (21) :3393-3401
[3]   PHENETHYLTHIAZOLETHIOUREA (PETT) COMPOUNDS, A NEW CLASS OF HIV-1 REVERSE-TRANSCRIPTASE INHIBITORS .1. SYNTHESIS AND BASIC STRUCTURE-ACTIVITY RELATIONSHIP STUDIES OF PETT ANALOGS [J].
BELL, FW ;
CANTRELL, AS ;
HOGBERG, M ;
JASKUNAS, SR ;
JOHANSSON, NG ;
JORDAN, CL ;
KINNICK, MD ;
LIND, P ;
MORIN, JM ;
NOREEN, R ;
OBERG, B ;
PALKOWITZ, JA ;
PARRISH, CA ;
PRANC, P ;
SAHLBERG, C ;
TERNANSKY, RJ ;
VASILEFF, RT ;
VRANG, L ;
WEST, SJ ;
ZHANG, H ;
ZHOU, XX .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (25) :4929-4936
[4]   Synthesis and activity of sulfonamide-substituted 4,5-diaryl thiazoles as selective cyclooxygenase-2 inhibitors [J].
Carter, JS ;
Kramer, S ;
Talley, JJ ;
Penning, T ;
Collins, P ;
Graneto, MJ ;
Seibert, K ;
Koboldt, CM ;
Masferrer, J ;
Zweifel, B .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (08) :1171-1174
[5]  
Ergenc N, 1999, ARCH PHARM, V332, P343, DOI 10.1002/(SICI)1521-4184(199910)332:10<343::AID-ARDP343>3.0.CO
[6]  
2-0
[7]   WinGX and ORTEP for Windows: an update [J].
Farrugia, Louis J. .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 2012, 45 :849-854
[8]   N-(4-SUBSTITUTED-THIAZOLYL)OXAMIC ACID-DERIVATIVES, A NEW SERIES OF POTENT, ORALLY ACTIVE ANTIALLERGY AGENTS [J].
HARGRAVE, KD ;
HESS, FK ;
OLIVER, JT .
JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (08) :1158-1163
[9]   Antitumor benzothiazoles. 16. Synthesis and pharmaceutical properties of antitumor 2-(4-aminophenyl)benzothiazole amino acid prodrugs [J].
Hutchinson, I ;
Jennings, SA ;
Vishnuvajjala, BR ;
Westwell, AD ;
Stevens, MFG .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (03) :744-747
[10]   4-(1,2,5,6-TETRAHYDRO-1-ALKYL-3-PYRIDINYL)-2-THIAZOLAMINES - A NOVEL CLASS OF COMPOUNDS WITH CENTRAL DOPAMINE AGONIST PROPERTIES [J].
JAEN, JC ;
WISE, LD ;
CAPRATHE, BW ;
TECLE, H ;
BERGMEIER, S ;
HUMBLET, CC ;
HEFFNER, TG ;
MELTZER, LT ;
PUGSLEY, TA .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (01) :311-317